Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nike Inc (NKE) vs 22nd Century Group Inc (XXII) Price & Performance

Nike IncTrade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

Nike Inc vs 22nd Century Group Inc — how do they compare? Nike Inc trades at $42.97 (market cap $64.49B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: Nike Inc is far larger — about 43281.9× 22nd Century Group Inc's market cap, and Nike Inc pays a 3.77% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.

NKEXXII
Market Cap
$64.49B$1.49M
Volume
8,887,180
Sector
Consumer CyclicalTechnology
52-Week High
$79.24$1.07K
52-Week Low
$40.75$3.90
Enterprise Value
$66.49B-$6.74M
Dividend Yield
3.77%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nike Inc

Nike (NKE) trades at $43.76, down 1.82% on the day, with a neutral technical signal and bullish moving averages. Recent earnings consistently beat expectations, with Q1 2026 EPS of $0.72 surpassing the $0.11 estimate. Revenue declined to $46.31B in 2025, while net income margin compressed to 6.7%. The stock holds a consensus analyst price target of $50.80, with 49% of analysts rating it a Buy. A dividend of $0.41 is scheduled for payment on July 1, 2026.

Nike's outlook is mixed: strong brand equity and earnings beats support upside potential, but revenue pressures and margin compression pose risks. Investors face trade-offs between valuation support and execution challenges in key markets like China. The stock's current discount to consensus target suggests cautious optimism amid turnaround efforts.

22nd Century Group Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Nike Inc

NIKE, Inc. designs, develops, and markets athletic footwear, apparel, equipment, and accessory products for men, women, and children. The Company sells its products worldwide to retail stores, through its own stores, subsidiaries, and distributors.

Read more on NKE

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII